Imperial College London Diabetes Centre

What Imperial College London Diabetes Centre does

Imperial College London Diabetes & Endocrine Centre (ICLDEC) is a state-of-the-art outpatient facility headquartered in Abu Dhabi, UAE, specialising in diabetes treatment, research, training, and public health awareness. Founded in 2006 and operating as part of the M42 health network, the centre was recently rebranded from "Imperial College London Diabetes Centre" to reflect a broader endocrine care mandate, and has expanded with a second branch at Madinat Zayed City in the Al Dhafra region. It serves individual patients across the UAE and internationally, alongside corporate wellness clients, schools, and healthcare professionals engaged through Continuing Medical Education programmes.

ICLDEC delivers the full diabetes care pathway in a single outpatient setting, spanning diabetes and endocrinology consultations, weight management, diabetes remission, cardiology, kidney health (including in-centre and home dialysis), podiatry, ophthalmology, dietetics, clinical psychology, laboratory, radiology, and pharmacy services, supplemented by an Alzheimer's blood test, medication home delivery, and a patient mobile app. Its underlying technology base rests on clinical specialisation and a partnership with Medtronic to operate the Middle East Centre of Reference for Automated Insulin Delivery, rather than proprietary software platforms; the centre does not disclose in-house AI/ML systems.

The business model is a multi-stream professional services operation: outpatient clinical consultations and procedures, diagnostic laboratory and imaging services, on-site pharmacy with delivery, and CME-accredited medical education and conferences. Pricing is quote-based and not publicly disclosed, with revenue routed through multiple insurance partners. Go-to-market is sales-led via direct appointments, physician referrals, international patient services, and community/public health outreach programmes targeting corporates and schools to drive early detection and brand-led patient acquisition.

Name

Imperial College London Diabetes Centre

Legal name

Imperial College London Diabetes & Endocrine Centre

Website

https://icldc.ae

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

501–1,000 employees

Short description

ICLDEC is an Abu Dhabi-based outpatient facility specialising in diabetes, endocrine, and metabolic care, operating within the M42 health network. It serves individual patients, corporates, and healthcare professionals across the UAE and wider region through multi-specialty clinical services, diagnostics, pharmacy, and CME programmes.

Ownership category

akta.pro rank

Product category

Outpatient Diabetes and Endocrine Care

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

Keywords

• Diabetes treatment services
• Endocrine specialty care
• Outpatient healthcare services
• Weight management clinic
• Medical education training

Headquarters

HQ city

Abu Dhabi

HQ country

United Arab Emirates

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Outpatient Clinical Services: Revenue generated from patient consultations, treatments, and medical procedures across diabetes, endocrinology, and related specialties in an outpatient setting.
2. Diagnostic Services: Revenue from laboratory tests, radiology services, and specialized diagnostics including HbA1c testing and other blood tests.
3. Pharmacy Services: On-site pharmacy providing medications to patients with medication delivery service option.
4. Medical Education and Training: Revenue from Continuing Medical Education (CME) programmes, training courses, and specialist conferences for healthcare professionals.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

ICLDEC is an outpatient facility in Abu Dhabi providing comprehensive diabetes and endocrine care services from first diagnosis through complication management, supported by specialty clinics in cardiology, kidney health (dialysis), podiatry, ophthalmology, dietetics, lipid, pharmacy, laboratory, radiology, and clinical psychology. It also runs medical education and training programmes for healthcare professionals and public health screening/outreach for corporates and schools.

Product overview

Imperial College London Diabetes & Endocrine Centre (ICLDEC) is a state-of-the-art outpatient facility that offers a comprehensive range of diabetes and endocrine care services. The centre provides a full spectrum of care from diagnosis through management of complications, including core services like Diabetes, Endocrinology, and Weight Management, complemented by supporting services such as Cardiology, Kidney Health, Podiatry, Ophthalmology, Dietetics, Clinical Psychology, and Laboratory/Radiology diagnostics. The centre also offers specialized services including Medication Delivery and Mobile App for patient convenience, along with public health programs featuring HbA1c testing for corporates and schools.

Differentiator

Problem solved

Functional benefit

Products and services

• Diabetes Services Comprehensive diabetes treatment and management services from first diagnosis through to management of all associated complications; for patients across all diabetes types and stages.
• Endocrinology Services Specialist endocrine care for hormone-related conditions including thyroid, adrenal, and metabolic disorders.
• Weight Management Clinic Obesity and bariatric weight loss surgery and management programmes for patients seeking weight management interventions.
• Diabetes Remission Programmes aimed at achieving and maintaining diabetes remission for eligible patients.
• Cardiology Services Cardiovascular care services for patients with diabetes-related heart conditions.
• Kidney Health Services State-of-the-art in-centre and home dialysis services for patients with advanced kidney complications.
• Podiatry Services Foot care specialist services for diabetes patients.
• Ophthalmology Services Eye care services including screening for diabetic retinopathy.
• Dietetic Services Nutritional counseling and diet management for diabetes patients.
• Diabetes Education Services Patient education programmes to support self-management of diabetes.
• Laboratory Services On-site laboratory testing and diagnostics.
• Radiology Services Imaging and radiology diagnostic services.
• Pharmacy Services On-site pharmacy with medication dispensing services including medication delivery.
• Clinical Psychology Mental health and psychological support services for diabetes patients.
• Lipid Clinic Cholesterol and lipid management services.
• Alzheimer's Blood Test Blood test service for Alzheimer's disease detection.
• Medication Delivery Service Home delivery service for prescriptions allowing patients to receive medications without visiting the pharmacy in person.
• Diabetes Self-Management Education Programme Structured education programme to help patients manage their diabetes effectively.
• Public Health HbA1c Testing and Workshops HbA1c testing and interactive workshops offered to corporates and schools to support regional diabetes awareness efforts.

Quantifiable outcome

• Nearly 4,000 people engaged in diabetes awareness campaigns
• +1 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered flagship, core and minor.

• M42flagshipStrategic or Co-development PartnerM42 is the parent network of Imperial College London Diabetes & Endocrine Centre. ICLDEC is described as an M42 network partner, providing access to the broader health ecosystem and integrated care across the network.
• MedtroniccoreStrategic or Co-development PartnerPartnership to establish Middle East Centre of Reference for Automated Insulin Delivery. This collaboration positions ICLDEC as a regional leader in diabetes technology and automated insulin delivery systems.
• HealthPlus Diabetes and Endocrinology CentercoreStrategic or Co-development PartnerOngoing collaboration on diabetes awareness campaigns (engaging nearly 4,000 people), annual diabetes conferences (1,000+ experts), World Diabetes Day events, and UAE Obesity Conference.
• Abu Dhabi Public Health Center (ADPHC)coreStrategic or Co-development PartnerCo-chairing the 7th UAE Obesity Conference 2025 with ICLDEC and Healthpoint, demonstrating public health collaboration for regional healthcare initiatives.
• Insurance PartnerscoreChannel Partner/ Reseller/ DistributorPartnership with multiple health insurers to offer healthcare coverage for patients, expanding access to care through accepted insurance plans.
• Make-A-Wish FoundationminorGTM or Marketing PartnerWorld Diabetes Day collaboration granting wishes of 11 children, building community engagement and awareness around diabetes.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Others

• International Diabetes Federation: Global umbrella organization for diabetes care, research, and policy. Adjacent ecosystem participant shaping awareness, guidelines, and research partnerships that ICLDEC engages with through its public health pillar.

Direct peers

• Joslin Diabetes Center: Harvard-affiliated global leader in diabetes care, research, and education. Globally recognized specialty diabetes provider that serves as the international benchmark for academic-affiliated diabetes centers like ICLDEC.
• King's College Hospital London Dubai: UK-academic-branded hospital in Dubai Hills. Operates on an analogous model of licensing a UK university hospital brand for premium specialty care in the UAE, addressing an overlapping international and insured patient base.
• Dubai Diabetes Centre: Dubai Health Authority-operated specialty diabetes center providing outpatient diabetes care. Comparable scope of services and serves the same regional patient pool, though under government rather than private ownership.
• Moorfields Eye Hospital Abu Dhabi: UK-academic-branded specialty outpatient facility in Abu Dhabi offering ophthalmology services including diabetic retinopathy screening. Closely comparable academic-brand single-specialty outpatient clinic model in the same city.
• HealthPlus Diabetes and Endocrinology Center: UAE-based specialty diabetes and endocrinology provider that has co-hosted conferences and awareness campaigns with ICLDEC. Most direct local peer sharing patient population, services, and payer relationships in Abu Dhabi.

Broad incumbents

• Cleveland Clinic Abu Dhabi: Major multi-specialty academic hospital in Abu Dhabi offering endocrinology among many other services. Provides overlapping diabetes care but across a much broader service portfolio, anchored by the Cleveland Clinic brand.
• Mediclinic Middle East: Large private hospital group operating across UAE offering endocrinology and diabetes services within broader multi-specialty hospitals. Competes for the same insured patient population but with a generalist footprint.
• NMC Healthcare: Large UAE private healthcare operator with multi-specialty hospitals including endocrinology. Competes for insured patients across Abu Dhabi and Dubai though not diabetes-specialized.

Regional players

• Saudi German Hospital Group: Major private hospital group in Saudi Arabia and broader MENA. Comparable academic-affiliated multi-specialty provider in neighboring GCC market relevant to medical tourism flow competing with UAE specialty clinics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ICLDC
• Facebookfacebook.com/ICLDCUAE
• LinkedInlinkedin.com/company/imperial-college-london-diabetes-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imperial College London Diabetes Centre